Soluble CD8 in patients with rheumatic diseases
Open Access
- 28 June 1990
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 80 (3), 354-359
- https://doi.org/10.1111/j.1365-2249.1990.tb03292.x
Abstract
An ELISA was used to measure soluble CD8 (sCD8) in the sera and synovial fluids (SF) of patients with rheumatic diseases. Patients with rheumatoid arthritis (RA) had raised levels of sCD8 both in their sera and in their SF compared with patients with osteoarthritis and age-matched healthy controls. In individual RA patients, serial serum sCD8 levels initially fell and then rose preceding clinical improvement. In four patients where serum sCD8 levels rose and clinical improvement occurred, subsequent spontaneous decreases of serum sCD8 level preceded increased clinical disease activity by up to 2 weeks. In general, RA SF mononuclear cells (SFMNC) spontaneously produced high levels of sCD8. In contrast, autologous peripheral blood MNC only produced comparable levels after mitogenic stimulation. Incubation of SFMNC with increasing concentrations of human recombinant tumour necrosis factor alpha resulted in a dose-dependent potentiation of sCD8 release into the supernatant. There was an inverse relationship between the ability of SFMNC to release sCD8 and soluble interleukin-2 receptor, indicating that the CD8+ T cell population may play an important immunoregulatory role in RA.Keywords
This publication has 32 references indexed in Scilit:
- Inflammatory Synovial T Cells in Different Activity Subgroups of Patients with Rheumatoid Arthritis and Juvenile Rheumatoid ArthritisScandinavian Journal of Rheumatology, 1989
- A second chain of human CD8 is expressed on peripheral blood lymphocytes.The Journal of Experimental Medicine, 1988
- Cell-cell adhesion mediated by CD8 and MHC class I moleculesNature, 1988
- Tumour necrosis factor in synovial exudates.Annals Of The Rheumatic Diseases, 1988
- Serum interleukin-2-receptor in rheumatoid arthritis: A prognostic indicator of disease activity?Journal of Autoimmunity, 1988
- Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha.The Journal of Experimental Medicine, 1987
- T Cell Subsets and the Recognition of MHC ClassImmunological Reviews, 1983
- Spontaneous release of the Leu-2 (T8) molecule from human T cells.The Journal of Experimental Medicine, 1983
- Analysis of T cell subsets in the peripheral blood and synovial fluid of patients with rheumatoid arthritis by means of monoclonal antibodies.Annals Of The Rheumatic Diseases, 1983
- Determination of T lymphocyte subpopulations by monoclonal antibodies in rheumatoid arthritis. Influence of immunomodulating agentsInternational Journal of Immunopharmacology, 1981